-
Evidence for the use of probiotics in a variety of medical conditions continues to accumulate.
-
The advisory committee on immunization practices (ACIP) of the CDC has updated their recommendations for immunization of health care providers (HCP) against communicable infectious diseases.
-
Between statin head-to-head trials are uncommon.
-
A meta-analysis demonstrates that earlier nephrologist referral leads to reduced mortality and hospitalization as well as better preparation and dialysis access placement.
-
Excessive daytime sleepiness appears to be an important risk factor for stroke. It is unknown whether this is related to obstructive sleep apnea or other mechanisms.
-
A new benzodiazepine anticonvulsant was recently approved for the treatment of a difficult-to-treat childhood epilepsy (Lennox-Gastaut syndrome [LGS]). Clobazam is manufactured by Catalent Pharma Solutions and marketed as ONFI.
-
-
This is the final article in a three-part series about the design and conduct of clinical research. The first installment discussed how research begins with the formulation of research questions, and the second reviewed the strengths and limitations of some common study designs. This article will discuss a few key issues in the analysis and interpretation of research findings.
-
Results from this small pilot trial suggest that clinical hypnosis, massage, and energy work can all be offered to people receiving chemotherapy without interfering with conventional medical care. The findings also suggest little clinical benefit, but there are considerable study limitations, and the findings speak more to feasibility than to therapeutic utility.
-
Behavioral therapy works as well as drug treatment for male overactive bladder.